A preliminary double-blind, single-dose, placebo-controlled, crossover, randomized to evaluate the safety, tolerability and biobehavioral effects of idazoxan co-administered with alcohol in healthy volunteers
Latest Information Update: 05 Apr 2016
At a glance
- Drugs Idazoxan (Primary)
- Indications Schizophrenia
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
Most Recent Events
- 05 Apr 2016 New trial record